Literature DB >> 8576208

Identification of the major site of rat prolactin phosphorylation as serine 177.

Y F Wang1, J W Liu, M Mamidi, A M Walker.   

Abstract

Phosphorylation of prolactin by endogenous protein kinases within isolated secretory granules was shown to result in the production of both phosphoserine and phosphothreonine residues. The majority of the radiolabel was determined to be present in the C terminus of the molecule after specific cleavage with glandular kallikrein. Glandular kallikrein cleaves in three places at the C terminus, liberating three small peptides, only one of which contains a phosphorylatable residue. Sequencing of this phosphopeptide showed it to be Arg175-Lys185. Thus the major site of prolactin phosphorylation was determined to be serine 177. Using a synthetic peptide equivalent to this region of the molecule (Ser161-Val180), serine 177 was demonstrated to be a substrate for protein kinase A as well as for one of the endogenous granule kinases. Inclusion of the synthetic peptide in an endogenous granule phosphorylation reaction resulted in competition for the kinase and reduced phosphorylation of prolactin. Protein kinase A phosphorylation of purified prolactin resulted in the production of only phosphoserine and primarily the most abundant (monophosphorylated) variant. We conclude that serine 177 is the major in vivo phosphorylation site of rat prolactin and that phosphorylation of this site can be reproduced by protein kinase A in vitro. The minor threonine phosphorylation site was demonstrated by two-dimensional tryptic peptide mapping and mass analysis to be either threonine 58 or 63, both of which are contained within a single peptide.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8576208     DOI: 10.1074/jbc.271.5.2462

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Paradigm-shifters: phosphorylated prolactin and short prolactin receptors.

Authors:  KuangTzu Huang; Eric Ueda; YenHao Chen; Ameae M Walker
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

2.  Unmodified prolactin (PRL) promotes PRL secretion and acidophil hypertrophy and is associated with pituitary hyperplasia in female rats.

Authors:  Terence E Johnson; Mayza Vue; Sharyn Brekhus; Amy Khong; Timothy W C Ho; Ameae M Walker
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

3.  Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells.

Authors:  Changhui Deng; Eric Ueda; Kuanhui E Chen; Craig Bula; Anthony W Norman; Richard A Luben; Ameae M Walker
Journal:  Mol Endocrinol       Date:  2008-12-12

Review 4.  S179D prolactin: antagonistic agony!

Authors:  Ameae M Walker
Journal:  Mol Cell Endocrinol       Date:  2007-06-28       Impact factor: 4.102

5.  S179D prolactin diminishes the effects of UV light on epidermal gamma delta T cells.

Authors:  Esther A Guzmán; John L Langowski; Ariel De Guzman; H Konrad Muller; Ameae M Walker; Laurie B Owen
Journal:  Mol Cell Endocrinol       Date:  2007-09-11       Impact factor: 4.102

Review 6.  What can we learn from rodents about prolactin in humans?

Authors:  Nira Ben-Jonathan; Christopher R LaPensee; Elizabeth W LaPensee
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

7.  GH kinase activity in bovine anterior pituitary subcellular fractions.

Authors:  J R Wicks; C L Brooks
Journal:  Endocrine       Date:  1999-02       Impact factor: 3.925

Review 8.  Prolactin receptor antagonists.

Authors:  C B Kuo; D Coss; A M Walker
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

9.  Estrogen induces phosphorylation of prolactin through p21-activated kinase 2 activation in the mouse pituitary gland.

Authors:  Kazunori Morohoshi; Yuichiro Komatani; Toshio Harigaya
Journal:  J Reprod Dev       Date:  2020-09-19       Impact factor: 2.214

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.